Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intersect ENT Inc (NASDAQ:XENT)

25.15
Delayed Data
As of May 26
 +1.15 / +4.79%
Today’s Change
7.65
Today|||52-Week Range
25.60
+107.85%
Year-to-Date
No recent news for Intersect ENT Inc.

Today’s Trading

Previous close24.00
Today’s open24.35
Day’s range24.05 - 25.60
Volume1,003,017
Average volume (3 months)301,015
Market cap$690.6M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+12.75%
Earnings growth (this year)+16.45%
Earnings growth (next 5 years)-18.10%
Revenue growth (last year)+30.11%
P/E ratioNM
Price/Sales4.37
Price/Book6.02

Competitors

 Today’s
change
Today’s
% change
GNMKGenMark Diagnostics ...+0.14+1.08%
CRYCryoLife Inc-0.15-0.82%
ANIKAnika Therapeutics I...-0.26-0.56%
ANGOAngioDynamics Inc-0.07-0.44%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateSeptember 6, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$78.7M
Annual profit (last year)-$25.2M
Net profit margin-32.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Lisa D. Earnhardt
COO, Senior VP-Research &
Development
Richard E. Kaufman
Corporate headquarters
Menlo Park, California

Forecasts